关注
Kenna Payne
Kenna Payne
TTUHSC School of Pharmacy
在 ttuhsc.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Multicenter evaluation of vancomycin dosing: emphasis on obesity
RG Hall, KD Payne, AM Bain, AP Rahman, ST Nguyen, SA Eaton, ...
The American journal of medicine 121 (6), 515-518, 2008
842008
Dosing of antifungal agents in obese people
KD Payne, RG Hall
Expert review of anti-infective therapy 14 (2), 257-267, 2016
392016
Dosing of antibacterial agents in obese adults: does one size fit all?
KD Payne, RG Hall
Expert review of anti-infective therapy 12 (7), 829-854, 2014
362014
Lipid‐Lowering Efficacy and Safety After Switching to Atazanavir‐Ritonavir‐Based Highly Active Antiretroviral Therapy in Patients with Human Immunodeficiency Virus
ST Nguyen, SA Eaton, AM Bain, AP Rahman, KD Payne, R Bedimo, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28 (3 …, 2008
342008
A standardized patient counseling rubric for a pharmaceutical care and communications course
N Horton, KD Payne, M Jernigan, J Frost, S Wise, M Klein, J Epps, ...
American journal of pharmaceutical education 77 (7), 152, 2013
302013
Safety and Efficacy of Simvastatin for the Treatment of Dyslipidemia in Human Immunodeficiency Virus‐Infected Patients Receiving Efavirenz‐Based Highly Active Antiretroviral …
AP Rahman, SA Eaton, ST Nguyen, AM Bain, KD Payne, R Bedimo, ...
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28 (7 …, 2008
212008
Multi-state medication take back initiative: Controlled substances collected from 2011 to 2015
JE Jaramillo-Stametz, H Stewart, L Ochs, K Payne
Journal of Substance Use 23 (1), 36-42, 2018
102018
Dosing strategies to optimize currently available anti-MRSA treatment options (Part 2: PO options)
KD Payne, A Das, M Ndiulor, RG Hall 2nd
Expert review of clinical pharmacology 11 (2), 139-149, 2018
32018
Dosing strategies to optimize currently available anti-MRSA treatment options (Part 1: IV options)
RG Hall 2nd, M Thatcher, W Wei, S Varghese, L Varughese, M Ndiulor, ...
Expert Review of Clinical Pharmacology 10 (5), 493-508, 2017
32017
Efficacy of pravastatin in non-nucleoside reverse transcriptase inhibitor (NNRTI) and protease inhibitor (PI)-based HAART in HIV-infected patients
SA Eaton, AP Rahman, ST Nguyen, AM Bain, KD Payne, AJ Busti
American Journal of Infectious Diseases 4 (2), 124-130, 2008
32008
Inside our medicine cabinets: Results from a multi-state medication take back initiative
L Ochs, J Jaramillo, H Stewart, K Payne
APHA 2017 Annual Meeting & Expo (Nov. 4-Nov. 8), 2017
2017
The Lipid-Lowering Efficacy of Switching Within Non-Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients
AM Bain, KD Payne, AP Rahman, R Bedimo, DO Maclayton, ...
American Journal of Infectious Diseases 4 (2), 147, 2008
2008
103: A Multi-center Retrospective Study of the Lipid-lowering Efficacy and Safety of Switching Within the NNRTI Class in HIV-infected Patients
A Bain, KD Payne, AP Rahman, R Bedimo, DO Maclayton, ...
Journal of Clinical Lipidology 1 (2), 149, 2007
2007
110: A Retrospective Study Evaluating the Safety and Efficacy of Simvastatin in Treating Hyperlipidemia in HIV-infected Patients on Efavirenz Based HAART
AP Rahman, K Payne, A Bain, S Nguyen, S Eaton, A Busti, R Bedimo
Journal of Clinical Lipidology 1 (2), 153, 2007
2007
109: A Multi-Center Retrospective Study on the Clinical Efficacy and Safety on Lipid Lowering Effects After a Switch to Atazanavir/Ritonavir Based HAART
ST Nguyen, SA Eaton, AJ Busti, A Bain, K Payne, A Rahman, R Bedimo, ...
Journal of Clinical Lipidology 1 (2), 152-153, 2007
2007
107: The Efficacy of Pravastatin in Non-neucleoside Reverse Transcriptase Inhibitor (NNRTI) and Protease Inhibitor (PI)-based HAART in HIV-infected Patients
SA Eaton, ST Nguyen, AP Rahman, AM Bain, KD Payne, AJ Busti
Journal of Clinical Lipidology 1 (2), 151-152, 2007
2007
系统目前无法执行此操作,请稍后再试。
文章 1–16